Glucocorticoid replacement is associated with hypertriglyceridaemia, elevated glucose and higher non-HDL cholesterol and may diminish the association of HDL cholesterol with the -629C>A CETP promoter polymorphism in GH-receiving hypopituitary patients.

R.P.F. Dullaart; J.L. Schols; G. van der Steege; P.M.J. Zelissen; W.J. Sluiter; A.P. van Beek

Glucocorticoid replacement is associated with hypertriglyceridaemia, elevated glucose and higher non-HDL cholesterol and may diminish the association of HDL cholesterol with the -629C>A CETP promoter polymorphism in GH-receiving hypopituitary patients.

Translated title of the contribution: Glucocorticoid replacement is associated with hypertriglyceridaemia, elevated glucose and higher non-HDL cholesterol and may diminish the association of HDL cholesterol with the -629C>A CETP promoter polymorphism in GH-receiving hypopituitary patients.

R.P.F. Dullaart
, J.L. Schols
, G. van der Steege
, P.M.J. Zelissen
, W.J. Sluiter
, A.P. van Beek

Internal Medicine

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Glucocorticoid replacement is associated with hypertriglyceridaemia, elevated glucose and higher non-HDL cholesterol and may diminish the association of HDL cholesterol with the -629C>A CETP promoter polymorphism in GH-receiving hypopituitary patients.
Original language	Undefined/Unknown
Pages (from-to)	359-366
Number of pages	8
Journal	Clinical Endocrinology
Volume	69
Issue number	3
Publication status	Published - 2008

Cite this

Dullaart, R. P. F., Schols, J. L., van der Steege, G., Zelissen, P. M. J., Sluiter, W. J., & van Beek, A. P. (2008). Glucocorticoid replacement is associated with hypertriglyceridaemia, elevated glucose and higher non-HDL cholesterol and may diminish the association of HDL cholesterol with the -629C>A CETP promoter polymorphism in GH-receiving hypopituitary patients. Clinical Endocrinology, 69(3), 359-366.

Dullaart, R.P.F. ; Schols, J.L. ; van der Steege, G. et al. / Glucocorticoid replacement is associated with hypertriglyceridaemia, elevated glucose and higher non-HDL cholesterol and may diminish the association of HDL cholesterol with the -629C>A CETP promoter polymorphism in GH-receiving hypopituitary patients. In: Clinical Endocrinology. 2008 ; Vol. 69, No. 3. pp. 359-366.

@article{7efb4e34da1e47488193ab0659a7cb30,

title = "Glucocorticoid replacement is associated with hypertriglyceridaemia, elevated glucose and higher non-HDL cholesterol and may diminish the association of HDL cholesterol with the -629C>A CETP promoter polymorphism in GH-receiving hypopituitary patients.",

author = "R.P.F. Dullaart and J.L. Schols and \{van der Steege\}, G. and P.M.J. Zelissen and W.J. Sluiter and \{van Beek\}, A.P.",

year = "2008",

language = "Undefined/Unknown",

volume = "69",

pages = "359--366",

journal = "Clinical Endocrinology",

issn = "0300-0664",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "3",

}

Dullaart, RPF, Schols, JL, van der Steege, G, Zelissen, PMJ, Sluiter, WJ & van Beek, AP 2008, 'Glucocorticoid replacement is associated with hypertriglyceridaemia, elevated glucose and higher non-HDL cholesterol and may diminish the association of HDL cholesterol with the -629C>A CETP promoter polymorphism in GH-receiving hypopituitary patients.', Clinical Endocrinology, vol. 69, no. 3, pp. 359-366.

Glucocorticoid replacement is associated with hypertriglyceridaemia, elevated glucose and higher non-HDL cholesterol and may diminish the association of HDL cholesterol with the -629C>A CETP promoter polymorphism in GH-receiving hypopituitary patients. / Dullaart, R.P.F.; Schols, J.L.; van der Steege, G. et al.
In: Clinical Endocrinology, Vol. 69, No. 3, 2008, p. 359-366.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Glucocorticoid replacement is associated with hypertriglyceridaemia, elevated glucose and higher non-HDL cholesterol and may diminish the association of HDL cholesterol with the -629C>A CETP promoter polymorphism in GH-receiving hypopituitary patients.

AU - Dullaart, R.P.F.

AU - Schols, J.L.

AU - van der Steege, G.

AU - Zelissen, P.M.J.

AU - Sluiter, W.J.

AU - van Beek, A.P.

PY - 2008

Y1 - 2008

M3 - Article

SN - 0300-0664

VL - 69

SP - 359

EP - 366

JO - Clinical Endocrinology

JF - Clinical Endocrinology

IS - 3

ER -

Dullaart RPF, Schols JL, van der Steege G, Zelissen PMJ, Sluiter WJ, van Beek AP. Glucocorticoid replacement is associated with hypertriglyceridaemia, elevated glucose and higher non-HDL cholesterol and may diminish the association of HDL cholesterol with the -629C>A CETP promoter polymorphism in GH-receiving hypopituitary patients. Clinical Endocrinology. 2008;69(3):359-366.